Cero Therapeutics Holdings CERO
OTC CERO
$0.01 +0.01 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings (CERO) Operating Expenses (2022 - 2026)

Updated

Cero Therapeutics Holdings (CERO) posted Operating Expenses of $3.85 million for Q2 2026, down 18.6% from $4.72 million a year earlier and down 20.6% from the prior quarter.

Analysis

Cero Therapeutics Holdings (CERO) Operating Expenses (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Cero Therapeutics Holdings was $17.48 million, up 8.1% year-over-year; for FY2025, it came in at $18.46 million, up 20.7% from FY2024.

  • Annual Operating Expenses has increased for four consecutive years, with a four-year compound annual growth rate of 173.1% (FY2021 to FY2025).
  • In prior years, Cero Therapeutics Holdings' Operating Expenses was $15.3 million in FY2024 (+99.4%), $7.68 million in FY2023 (+164.2%), $2.91 million in FY2022 (+775.1%) and $332,030 in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Operating Expenses since Q4 2024.
  • On a year-over-year basis, Operating Expenses increased in four of the last eight quarters, with growth averaging 48.8%.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q2 2023, with growth of 541.0%; the weakest was Q2 2026, with a decline of 18.6%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $4.85 million (Q1 2026), $4.43 million (Q4 2025) and $4.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 11.12 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 10.56 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 9.70 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 18.20 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 6.68 Bn
10 Cero Therapeutics Holdings 638,128.24 -4.84 Mn - 3.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.85 Mn
Mar 31, 2026 4.85 Mn
Dec 31, 2025 4.43 Mn
Sep 30, 2025 4.36 Mn
Jun 30, 2025 4.72 Mn
Mar 31, 2025 4.95 Mn
Dec 31, 2024 2.10 Mn
Sep 30, 2024 4.40 Mn
Jun 30, 2024 5.15 Mn
Mar 31, 2024 3.65 Mn
Dec 31, 2023 1.12 Mn
Sep 30, 2023 1.54 Mn
Jun 30, 2023 2.41 Mn
Mar 31, 2023 2.44 Mn
Dec 31, 2022 1.29 Mn
Sep 30, 2022 836,685.00
Jun 30, 2022 376,580.00
Mar 31, 2022 404,777.00
API Access

Cero Therapeutics Holdings Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CERO&period=max&api_key=YOUR_API_KEY